Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Conserved telomere maintenance component 1 (CTC1) is the largest subunit of the CST (CTC1–STN1–TEN1) complex, a trimeric protein complex essential for the replication and maintenance of telomeres in eukaryotic cells[1][2][3][5]. The CST complex binds single-stranded telomeric DNA, regulates telomerase activity, and is crucial for the synthesis of the telomeric C-strand, especially during late S/G2 phase of the cell cycle[1][4][5]. CTC1 helps to restart stalled replication forks during replication stress and works in conjunction with DNA polymerase alpha (Polα) to promote efficient telomere replication and C-strand fill-in[1][3][4]. Loss of CTC1 results in catastrophic telomere loss, genome instability, bone marrow failure, and a spectrum of human diseases, highlighting its critical role in genome integrity[1][2][5][6]. Mutations in the CTC1 gene have been directly implicated in the pathogenesis of disorders such as Coats plus syndrome, dyskeratosis congenita, and other telomere spectrum disorders[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Conserved telomere maintenance component 1 (CTC1).